FGF23 and hyperphosphatemia: However, an additive effect between FGF23 and HP on inducing cardiac hypertrophy and energy metabolism changes was observed, indicating that end-stage renal disease (ESRD) or dialysis patients with hyperphosphatemia and high FGF23 levels may suffer more from myocardial hypertrophy.